Calendar Year Performance 2015Calendar Year Performance 2016Calendar Year Performance 2017Calendar Year Performance 2018Calendar Year Performance 2019Calendar Year Performance 2020Calendar Year Performance 2021Calendar Year Performance 2022Calendar Year Performance 2023Calendar Year Performance 2024
-
-
-
-
-
-
- 35.6 %
- 5.2 %
- 22.5 %
+ 1.0 %
Net Asset Value
46.89 €
Asset Under Management
54 M €
Market
Emerging markets
SFDR - Fund Classification
Article
8
Data as of: 31 Dec 2024.
Data as of: 17 Jan 2025.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged. The Sustainable Finance Disclosure Regulation (SFDR) 2019/2088 is a European regulation that requires asset managers to classify their funds as either 'Article 8' funds, which promote environmental and social characteristics, 'Article 9' funds, which make sustainable investments with measurable objectives, or 'Article 6' funds, which do not necessarily have a sustainability objective. For more information please refer to https://eur-lex.europa.eu/eli/reg/2019/2088/oj.
Chinese markets rose in December, ending a year of strong gains.
Economic indicators were mixed over the month, with the NBS manufacturing PMI down (50.5 in December compared with 51.5 in November) and the non-manufacturing PMI up (52.2 in December compared with 50 in November).
China's leaders have reaffirmed their intention to step up fiscal measures in the months ahead, particularly during the Two Sessions in March.
Over the month, the indices were up by 5.53% for the Hang Seng and 1.55% for the CSI 300.
Performance commentary
Against this backdrop, the fund delivered a positive performance in line with its reference indicator.
Our strategy benefited greatly from its allocation to the technology sector, particularly Taiwanese companies such as TSMC, Wiwynn and Elite Material.
Our portfolio of Chinese consumer discretionary stocks also made a positive contribution to performance, such as New Oriental Education, Yadea and H world.
Finally, we also benefited from our holdings in industrial stocks Sinotrans Ltd, which is involved in logistics activities, and EHang, which offers mobility solutions.
Outlook strategy
Although we remain constructive on the Chinese markets in the long term, we are maintaining a cautious stance in the short term, as we await further stimulus announcements from the Chinese government in the wake of Donald Trump's election as President of the United States.
Indeed, Donald Trump's protectionist policies, with tariffs on imports, mainly from China, and the ‘Two Sessions’ in March, are keeping the wind of uncertainty blowing.
We are closely monitoring each of our Chinese positions and their valuation, with the aim of remaining disciplined in calibrating our positions. We have taken profits on some of our Chinese positions, which have rebounded strongly in recent days, and for which the valuation argument has become less attractive.
Over the month, we added two stocks to our portfolio: Gudeng Precision Industrial, a manufacturer of photographic moulds for the semiconductor industry, and we invested in Mao Geping Cosmetics, a Chinese player in the cosmetics industry.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performance is shown net of fees (excluding any subscription fees payable to the distributor). Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.
Carmignac Portfolio is a sub-fund of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.
Unsupported browserWe've noticed that your browser is no longer supported. To ensure optimal performance and security while using our website, we recommend updating your browser or other relevant software. Thank you for your understanding!
Market environment